StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > 27 000 Barbados travelers per week

<< Previous

Bullboard Posts

Next >>

Comment by RelevantStockon Dec 08, 2020 9:27am

105 Views

Post# 32056777

RE:RE:27 000 Barbados travelers per week

Aye! Sorry!! I thought it was high indeed, but then read "Over 2.4m passengers travel to and from Barbados annually." on the Barbados website... But I think you're right sorry for the mistake.

https://www.barbadostourisminvestment.com/tourism-profile/#:~:text=Over%202.4m%20passengers%20travel%20to%20and%20from%20Barbados%20annually.

Newfinvest wrote: Correction... I heard 2700 weekly flying to Barbados. Still very good as this is just one contract and it is with SZLS... and of course that is current numbers. There may be more travlers as we get into winter months.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec